长风药业股份有限公司（02652）于2025年12月31日发布翌日披露报表，公告当日以每股最高价36港元、最低价33.34港元在香港联交所回购43,000股H股，涉资约145.65万港元。该回购股份占公司既有已发行股份（不包括库藏股）约0.0142%。本次回购完成后，公司已发行股份数目为302,156,586股，库藏股数目增至67,000股。
公告显示，公司购回授权于2025年12月16日获得通过，可回购总数为30,222,358股。截至本次披露，累计已回购股份总数为67,000股，占获授权股份总数约0.0222%。公告中公司确认已遵守《香港联合交易所有限公司证券上市规则》等相关法律法规，公告由执行董事及联席公司秘书朱玉玉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.